CAS: 155069-90-2 - CALCITONIN (8-32) (SALMON I)
Formula:C119H198N36O37
- Sinonimi:
- Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-Nh2
- H-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-Nh2
- Calcitonin (8-32), Salmon
Marchio | Dati del prodotto | Purezza | Fascia di prezzo | Consegna prevista |
---|---|---|---|---|
Calcitonin (8-32) (salmon I) REF: 01-4037182CAS: 155069-90-2 | > 97% | 238,00 €~410,00 € | Mar 28 Mag 24 | |
Calcitonin (8-32), salmon REF: TM-TP1677CAS: 155069-90-2 | 98% | Prezzo su richiesta | Mar 04 Giu 24 | |
Calcitonin (8-32) (salmon I) trifluoroacetate salt REF: 3D-FC109515CAS: 155069-90-2 | Min. 98 Area-% | 108,00 €~526,00 € | Mer 12 Giu 24 |
Calcitonin (8-32) (salmon I)
CAS:155069-90-2
Calcitonin (8-32) (salmon I) has been been proposed as an amylin receptor antagonist which is …
Formula:
C119H198N36O37
Purezza:
> 97%
Colore e forma:
White Lyophilisate
Peso molecolare:
2725.1
Ref: 01-4037182
1mg | 410,00 € | |
0.5mg | 238,00 € |
Consegna stimata in Stati Uniti, il Martedì 28 Maggio 2024
Calcitonin (8-32), salmon
CAS:155069-90-2
Calcitonin (8-32), salmon is a highly selective amylin receptor antagonist.Calcitonin is a hormone known to …
Formula:
C119H198N36O37
Purezza:
98%
Colore e forma:
Solid
Peso molecolare:
2725.06
Ref: TM-TP1677
100mg | Prezzo su richiesta | |
500mg | Prezzo su richiesta |
Consegna stimata in Stati Uniti, il Martedì 04 Giugno 2024
Calcitonin (8-32) (salmon I) trifluoroacetate salt
CAS:155069-90-2
Please enquire for more information about Calcitonin (8-32) (salmon I) H-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-P including the price, delivery …
Formula:
C119H198N36O37
Purezza:
Min. 98 Area-%
Colore e forma:
Powder
Peso molecolare:
2,725.07 g/mol
Ref: 3D-FC109515
10µg | 108,00 € | |
25µg | 172,00 € | |
50µg | 242,00 € | |
100µg | 364,00 € | |
250µg | 526,00 € |
Consegna stimata in Stati Uniti, il Mercoledì 12 Giugno 2024